武漢帝康醫(yī)藥，華中地區(qū)大型來那替尼原料供應(yīng)基地，湖北原藥來那替尼原料誠信供應(yīng)商！
優(yōu)質(zhì)來那替尼現(xiàn)貨，出廠來那替尼價(jià)格直銷，可詢價(jià)訂單，樣品費(fèi)用全額返還！
帝康醫(yī)藥，歡迎您來電來函，期待與您合作！
來那替尼
中文名稱：(2E)-N-[4-[[3-氯-4-[(吡啶-2-基)甲氧基]苯基]氨基]-3-氰基-7-乙氧基喹啉-6-基]-4-(二甲基氨基)丁-2-烯酰胺
中文別名：來那替尼
英文名稱：Neratinib
英文別名：(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide;
CAS號(hào)： 698387-09-6
分子式：C30H29ClN6O3
分子量：557.0427
外觀：淡黃色至黃色結(jié)晶性粉末
分子結(jié)構(gòu)：
密度：1.337g/cm3
沸點(diǎn)：756.97°C at 760 mmHg
閃點(diǎn)：411.601°C
蒸汽壓：0mmHg at 25°C
溶解性：DMSO：≥3.6mg/mL，水：<1.2mg/mL，乙醇：≥1.8mg/mL
用途及描述：科研試劑，廣泛應(yīng)用于分子生物學(xué)，藥理學(xué)等科研方面。來那替尼是一種口服有效的、不可逆的酪氨銷售，也抑制HER2和EGFR
儲(chǔ)存條件：-20° C，避光防潮密閉干燥。
注意：我司產(chǎn)品為非無菌包裝，若用于細(xì)胞培養(yǎng)，請(qǐng)?zhí)崆白鲱A(yù)處理，除去熱原細(xì)菌，否則會(huì)導(dǎo)致染菌。以上數(shù)據(jù)僅供參考交流之用
The structure of EGFR contains the extracellular domains and transmembrane domains. Among them, the intracellular domain is mainly divided into different parts including juxtamembrane domain, tyrosine kinase domain, and regulatory region domain. The tyrosine kinase domain of EGFR consists of the N-lobe and C-lobe flanking the activation loop and active site cleft. Threonine 790 is the gatekeeper residue of EGFR, which locates at the entrance to a hydrophobic pocket in the back of the ATP binding cleft and thus determines inhibitor specificity in protein kinases. Substitution of threonine 790 with methionine (T790M) causes resistance by steric interference with binding of tyrosine kinase inhibitors.
The crystal structure reveals the covalent binding of WZ4002 to the ATP-binding cleft of EGFR T790M mutant. The covalent bond is formed between Cys797 and the acrylamide group of WZ4002. Non-covalent interactions also enhance the affinity between WZ4002 and kinase domain. The anilinopyrimidine core of WZ4002 forms a bidentate hydrogen bonding interaction with Met793, and the chlorine substituent on the pyrimidine ring contacts Met790, the mutant gatekeeper residue. Besides, the aniline ring also contacts the α-carbon of Gly796 via a hydrophobic interaction, with its methoxy substituent extending toward Leu792 and Pro794 in the hinge region. Furthermore, the ‘linker’ phenyl ring lies roughly perpendicular to the pyrimidine core, and this orientation juxtaposes the acrylamide with the thiol of Cys797 for covalent bond formation. The interactions determine the potency and relative selectivity of WZ4002 for EGFR T790M.
武漢帝康醫(yī)藥原料有限公司，是一家專注于化工產(chǎn)品研發(fā)和生產(chǎn)的企業(yè)，竭誠為客戶提供優(yōu)質(zhì)的產(chǎn)品和服務(wù)。帝康醫(yī)藥擁有強(qiáng)力的研發(fā)和管理團(tuán)隊(duì)嚴(yán)格把關(guān)產(chǎn)品質(zhì)量，為客戶提供人性化的服務(wù)，以及多樣化的包裝規(guī)格和優(yōu)于市場(chǎng)的價(jià)格。
公司始終秉承價(jià)格存之本的宗旨，以過硬的質(zhì)量和優(yōu)良的價(jià)格體系維護(hù)和拓展市場(chǎng)，zui大限度的滿足客戶的需求。帝康醫(yī)藥，歡迎您來電來函，期待與您合作??！
采購中心
